ACET

Conviction 48HealthcareScan · Mon, Aug 10, 2026

Shooting star

ACET$8.06+1.00%

ResistanceSupportVol 14Insider buyInsider sell

Vol MA14 105.65K

May 11May 28Jun 16Jul 6Jul 23Aug 10

Adicet Bio, Inc.PHARMACEUTICAL PREPARATIONSwww.adicetbio.com ↗

Price8.06

Change+1.00%

Gap+0.25%

Rel volume1.66×

Avg volume99.49K

Avg $ vol838.97K

SMA 208.45

SMA 508.34

SMA 2006.15

Price vs 50-3.32%

Price vs 200+31.00%

MA stackmixed

50/200 cross—

Supertrenddown · 9.42

RSI (14)44

MACD hist-0.07

MACD crossbear · 1d

Stoch %K / %D27 / 24

ADX (14)17

+DI / −DI19 / 27

RSI divergence—

MACD divergence—

ATR %+7.21%

ADR %6.63%

52w high9.31

52w low0.4650

From 52w high-13.43%

Above 52w low+1633.33%

New 52w highNo

SqueezeOff

Bollinger width22.77%

%B0.30

Donchian pos26.50%

Donchian high9.84

Donchian low7.42

AVWAP (52w high)8.57

vs AVWAP high-5.93%

AVWAP (52w low)4.37

vs AVWAP low+84.27%

OBV trendFlat

Chaikin MF (20)-0.04

Today vs 20d1.66×

Avg vol (14d)105.65K

Avg vol (20d)99.49K

Avg $ vol (20d)838.97K

Market cap75.45M

RS 3m (vs SPY)-9.78%

RS 6m (vs SPY)+9.80%

RS line new highNo

Trend template6/8

Technical rank55.9

1 week-12.77%

1 month-8.72%

3 months-5.73%

6 months+14.65%

1 year+1073.05%

YTD-8.62%

P/E-0.65

P/B0.63

P/S—

P/FCF-0.78

EPS-16.95

Div yield—

ROE-97.22%

ROA-78.83%

Debt/Eq—

Current6.71

EV/EBITDA-0.37

Gross margin—

Net margin—

Rev growth—

EPS growth0.27%

Price target—

Target upside—

Analyst rating—

Institutional—

Ent. value42.32M

Revenue—

Net income-21.36M

Gross profit—

Free cash flow-96.98M

IndustryPHARMACEUTICAL PREPARATIONS

ExchangeNasdaq

Shares out9.35M

Employees102

ListedWed, Sep 16, 2020

Free float8.16M

Float %85.2%

Short interest383.17K

Days to cover4.3d

Short volume43.3%

Squeeze score43 / 100

Next earnings—

EPS forecast—

Last EPS vs est−$1.99 vs −$2.43

Last surprise+18.1% beat

Setup gradeC

Conviction48 / 100

Pattern quality—

Tech rank55.9 / 100

Group rank86 / 100 · Leading

Status lane—

Setup direction—

Pattern family

Resistance—

Support—

Days since event—

Candle confirmShooting star

News sentiment—

Financials as of Tue, Jun 30, 2026 · quarterly.

Congress activity

Disclosed STOCK Act trades in ACET

All disclosures →

No recent disclosed trades by Congress in ACET. STOCK Act filings can lag the trade by up to 45 days.

Insider activity

SEC Form 4 transactions in ACET · 6 buys · 4 sells

Insider	Side	Shares	Value	Traded	Filed
Klickstein Lloyd Chief Medical Officer · Stock Option (Right to Buy) · 2026-08-05	Grant	18.3K	—	2026-08-05	2026-08-07
RA CAPITAL MANAGEMENT, L.P. 10% owner · Common Stock · 2026-04-27	Dispose	250K	—	2026-04-27	2026-04-29
Kolchinsky Peter 10% owner · Pre-Funded Warrant (Right to Buy) · 2026-04-27	Acquire	250K	—	2026-04-27	2026-04-29
RA Capital Healthcare Fund LP 10% owner · Common Stock · 2026-04-27	Dispose	250K	—	2026-04-27	2026-04-29
RA CAPITAL MANAGEMENT, L.P. 10% owner · Pre-Funded Warrant (Right to Buy) · 2026-04-27	Acquire	250K	—	2026-04-27	2026-04-29
Shah Rajeev M. 10% owner · Common Stock · 2026-04-27	Dispose	250K	—	2026-04-27	2026-04-29
RA Capital Healthcare Fund LP 10% owner · Pre-Funded Warrant (Right to Buy) · 2026-04-27	Acquire	250K	—	2026-04-27	2026-04-29
Kolchinsky Peter 10% owner · Common Stock · 2026-04-27	Dispose	250K	—	2026-04-27	2026-04-29
Shah Rajeev M. 10% owner · Pre-Funded Warrant (Right to Buy) · 2026-04-27	Acquire	250K	—	2026-04-27	2026-04-29
Shah Rajeev M. 10% owner · Common Stock · 2026-02-20	Buy	74.75K	$543K	2026-02-20	2026-04-13

SEC filings

EDGAR filings in ACET · 3 recent

EDGAR →

Get daily signals & real-time alerts.

StockSetups scans ~12,300 US stocks & ETFs after every close and sorts every long setup into four ranked lanes — each with a trade plan — plus an always-on engine firing 35+ real-time intraday alerts. Free for 14 days, cancel in one click.

Start free — 14-day full access →

Educational data, not financial advice. Patterns, levels and the trade plan are algorithmic, not a recommendation to trade.